Laddar...
Case Report: Low Dose of Valsartan/Sacubitril Leads to Successful Reversal of Acute Heart Failure in Chemotherapy-Induced Cardiomyopathy
Valsartan/sacubitril is a new agent approved for the treatment of chronic heart failure in adults, with a combination of angiotensin receptor inhibitor and neprilysin inhibitor. However, the benefit of valsartan/sacubitril in pediatric patients is unknown. We herein report its clinical benefit in a...
Sparad:
| I publikationen: | Front Pediatr |
|---|---|
| Huvudupphovsmän: | , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Frontiers Media S.A.
2021
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7959725/ https://ncbi.nlm.nih.gov/pubmed/33732669 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fped.2021.639551 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|